Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
S&P Global Ratings has reconfirmed Romania's sovereign debt rating at BBB-/A-3 for long-term and short-term debt on 3 April 2026, while maintaining the negative outlook.
Romania's Ministry of Finance has announced the April 2026 edition of Fidelis government bonds, offering tax-free interest rates of up to 7.6% for RON-denominated issues.
As Easter approaches, Romanians are preparing their shopping lists for gifts, food and household items.
CITR, the judicial administrator of Șantierul Naval din Mangalia, announced that the creditors' assembly has rejected the proposed reorganisation plan for the company.
Auchan Romania is consolidating its transition to green energy, accelerating the integration of renewable sources in its operations.